Sarepta Therapeutics | Kundefordringer

Trade Debtors Endring Dato
Acadia Pharmaceuticals USD 100.08M 2.27M 2024-03
Agios Pharmaceuticals USD 3.45M 643K 2024-03
Alnylam Pharmaceuticals USD 321.38M 6.41M 2024-03
Amgen USD 6.78B 492M 2024-03
Avrobio USD 0 270K 2023-12
Biogen USD 2B 100.3M 2024-03
BioMarin Pharmaceutical USD 637.16M 3.46M 2024-03
Eli Lilly USD 10.01B 350.3M 2024-03
Gilead Sciences USD 4.67B 9M 2024-03
Incyte USD 745.53M 1.97M 2024-03
Insmed USD 37.16M 4.03M 2024-03
Ionis Pharmaceuticals USD 5.14M 92.64M 2024-03
Moderna USD 387M 694M 2024-03
Neurocrine Biosciences USD 450.7M 32.9M 2024-03
Pfizer USD 15.22B 219M 2024-03
PTC Therapeutics USD 197.66M 36.84M 2024-03
Regeneron Pharmaceuticals USD 5.22B 445.1M 2024-03
Roche Holding CHF 11.36B 560M 2023-06
Sarepta Therapeutics USD 419.38M 65.12M 2024-03
Ultragenyx Pharmaceutical USD 100.25M 20.99M 2024-03
Vertex Pharmaceuticals USD 1.79B 254.5M 2024-03



Sarepta Therapeutics Kundefordringer - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.